Vifor (International) AG, a leading player in the pharmaceutical industry, is headquartered in Switzerland (CH) and operates extensively across Europe and North America. Founded in 2000, the company has established itself as a specialist in iron deficiency and related disorders, focusing on innovative therapies that enhance patient care. Vifor Pharma, a common variation of the name, is renowned for its unique portfolio of products, including intravenous iron therapies and oral iron supplements. These offerings are distinguished by their efficacy and safety profiles, addressing the needs of patients with chronic conditions. With a strong market position, Vifor (International) AG has achieved significant milestones, including strategic partnerships and a commitment to research and development. This dedication has solidified its reputation as a trusted provider in the healthcare sector, making a meaningful impact on the lives of patients worldwide.
How does Vifor (International) AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vifor (International) AG's score of 41 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Vifor (International) AG, headquartered in Switzerland (CH), currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of CSL Limited, which cascades its climate commitments and targets down to Vifor. While Vifor does not have its own documented reduction targets, it aligns with the sustainability initiatives of CSL Limited, which is committed to reducing its carbon footprint. This includes participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are managed at the corporate level by CSL Limited. As a subsidiary, Vifor benefits from the overarching climate strategies and performance metrics set by CSL Limited, which aims to enhance sustainability across its operations. However, specific details regarding Vifor's individual climate commitments or reduction achievements are not disclosed. In summary, while Vifor (International) AG does not provide its own emissions data or reduction targets, it is integrated into the broader climate strategy of CSL Limited, reflecting a commitment to sustainability within its corporate family.
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | - | - |
| Scope 3 | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Vifor (International) AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.